4.6 Article

TFPI-dependent activities of Protein S

期刊

THROMBOSIS RESEARCH
卷 129, 期 -, 页码 S23-S26

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2012.02.024

关键词

TFPI; protein S; APC; anticoagulants

资金

  1. Baxter Innovations GmbH

向作者/读者索取更多资源

Protein S is an essential anticoagulant protein that acts as a cofactor for full length tissue factor pathway inhibitor (TFPI) and activated protein C (APC) in the down regulation of coagulation. Protein S enhances APC-mediated inactivation of the coagulation factors Va and VIIIa, and it stimulates inhibition of factor (F) Xa by TFPI. Because TFPI is a tight binding, but slow inhibitor of FXa, the TFPI/protein S system fails to regulate FXa generation at high tissue factor/FVIIa concentrations. In this review, we explain how TFPI/protein S can regain its activity at high tissue factor concentrations in the presence of APC, resulting in an intertwinement of TFPI- and APC-cofactor activities of protein S, and making TFPI a major determinant of APC-anticoagulant activity in plasma. (C) 2012 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear

Johana Hrdinova, Delia I. Fernandez, Bogac Ercig, Bibian M. E. Tullemans, Dennis P. L. Suylen, Stijn M. Agten, Kerstin Jurk, Tilman M. Hackeng, Karen Vanhoorelbeke, Jan Voorberg, Chris P. M. Reutelingsperger, Kanin Wichapong, Johan W. M. Heemskerk, Gerry A. F. Nicolaes

Summary: This study designed and synthesized stable cyclic peptides to interfere with the interaction between VWF A1 domain and GPIb alpha. The selected peptides showed low binding free energy and retained their interference in the binding of VWF to GPIb-V-IX, as confirmed by flow cytometry. These peptides phenotypically mimicked the changes seen with the anti-VWF A1 domain antibody CLB-RAg35, although they were less potent. The improved peptide opt-mono-ORbIT demonstrated increased inhibitory activity under flow.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Differential Effects of Platelet Factor 4 (CXCL4) and Its Non-Allelic Variant (CXCL4L1) on Cultured Human Vascular Smooth Muscle Cells

Dawid M. Kaczor, Rafael Kramann, Tilman M. Hackeng, Leon J. Schurgers, Rory R. Koenen

Summary: Platelet factor 4 (CXCL4) is a chemokine stored in platelets that modulates the function of vascular smooth muscle cells (VSMCs). Variant CXCL4L1, despite minor differences, has distinct effects on VSMCs compared to CXCL4. Both CXCL4 and CXCL4L1 regulate gene expression, but only CXCL4 increases VSMC proliferation and calcification.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Multidisciplinary

Desymmetrization via Activated Esters Enables Rapid Synthesis of Multifunctional Benzene-1,3,5-tricarboxamides and Creation of Supramolecular Hydrogelators

Shahzad Hafeez, Huey Wen Ooi, Dennis Suylen, Hans Duimel, Tilman M. Hackeng, Clemens van Blitterswijk, Matthew B. Baker

Summary: Supramolecular materials based on BTA offer a way to mimic fibrous proteins found in nature, but current methods face limitations in BTA structure diversity and purification. We developed a desymmetrization method using activated ester coupling to rapidly synthesize multifunctional BTAs. These BTAs can self-assemble into hydrogels that display fiber-like structures and high cytocompatibility, making them suitable for tissue engineering applications.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Hematology

Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa

Anja Maag, Nienke van Rein, Tim J. Schuijt, Wil F. Kopatz, Danielle Kruijswijk, Stella Thomassen, Tilman M. Hackeng, Rodney M. Camire, Tom van der Poll, Joost C. M. Meijers, Mettine H. A. Bos, Cornelis van't Veer

Summary: Plasma thrombin generation provides important information on coagulation status, but current parameters do not predict major bleeding in patients on anticoagulants. Activation of factor V by factor Xa contributes significantly to thrombin generation, with greater activation associated with increased risk of major bleeding during VKA therapy.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Thrombin in complex with dabigatran can still interact with PAR-1 via exosite-I and instigate loss of vascular integrity

Sophie C. Dolleman, Stijn M. Agten, Henri M. H. Spronk, Tilman M. Hackeng, Mettine H. A. Bos, Henri H. Versteeg, Anton Jan van Zonneveld, Hetty C. de Boer

Summary: This study investigated the potential effects of different DOACs on vascular integrity. The results showed that the anti-FXa DOAC rivaroxaban preserved endothelial barrier function, while the anti-thrombin DOAC dabigatran failed to protect endothelial integrity over time. However, the loss of barrier function caused by dabigatran could be prevented by a mimicking peptide that blocks thrombin's exosite-I.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Targeting platelet-derived CXCL12 impedes arterial thrombosis

Julian Leberzammer, Stijn M. Agten, Xavier Blanchet, Rundan Duan, Hans Ippel, Remco T. A. Megens, Christian Schulz, Maria Aslani, Johan Duchene, Yvonne Doring, Natalie J. Jooss, Pengyu Zhang, Richard Brandl, Konstantin Stark, Wolfgang Siess, Kerstin Jurk, Johan W. M. Heemskerk, Tilman M. Hackeng, Kevin H. Mayo, Christian Weber, Philipp von Hundelshausen

Summary: The study explored the molecular mechanisms of CXCL12 in arterial thrombosis, revealing that inhibition of CXCR4 can attenuate platelet aggregation and limit arterial thrombosis. Mechanistically, CXCL12 activates Btk leading to platelet aggregation, while the interaction between CXCL12 and CCL5 can inhibit this process. A novel peptide was found to inhibit CXCL12-induced platelet aggregation without prolonging bleeding time.
Article Hematology

Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein S

Josepha C. Sedzro, Frederic Adam, Claire Auditeau, Elsa Bianchini, Allan De Carvalho, Ivan Peyron, Sadyo Darame, Sophie Gandrille, Stella Thomassen, Tilman M. Hackeng, Olivier D. Christophe, Peter J. Lenting, Cecile Denis, Delphine Borgel, Francois Saller

Summary: The research team generated a PS-specific sdAb (PS003) that enhances the APC-cofactor activity of PS, showing an anti-thrombotic effect in a mouse model. This innovative approach might represent a promising and safe antithrombotic strategy.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Article Multidisciplinary Sciences

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy

Judy R. van Beijnum, Elisabeth J. M. Huijbers, Karlijn van Loon, Athanasios Blanas, Parvin Akbari, Arno Roos, Tse J. Wong, Stepan S. Denisov, Tilman M. Hackeng, Connie R. Jimenez, Patrycja Nowak-Sliwinska, Arjan W. Griffioen

Summary: Anti-angiogenic cancer therapies have immune-stimulatory properties. This study found that tumor endothelial cells overexpress and secrete the protein vimentin, which promotes angiogenesis and inhibits leukocyte-endothelial interactions. Targeting extracellular vimentin shows inhibition of angiogenesis and tumor growth, and induces a pro-inflammatory condition in the tumor.

NATURE COMMUNICATIONS (2022)

Article Medicine, Research & Experimental

Application of the mineral-binding protein fetuin-A for the detection of calcified lesions

Robert Dzhanaev, Christian Hasberg, Andrea Gorgels, Carlo Schmitz, Camilla Franziska Winkler, Hanna Malyaran, Steffen Graeber, Anouk Gentier, Armand Jaminon, Stijn Agten, Tilman Hackeng, Asim Cengiz Akbulut, Leon Schurgers, Felix Manuel Mottaghy, Claudia Goettsch, Willi Jahnen-Dechent

Summary: This study developed a novel highly sensitive fluorescent probe based on fetuin-A for imaging microcalcifications. The probe showed non-toxicity and the ability to detect microcalcifications beyond the detection limit of conventional staining techniques. This fetuin-A-based probe has the potential for clinical applications.

THERANOSTICS (2023)

Article Engineering, Biomedical

Thiol-ene conjugation of a VEGF peptide to electrospun scaffolds for potential applications in angiogenesis

Tianyu Yao, Honglin Chen, Rong Wang, Rebeca Rivero, Fengyu Wang, Lilian Kessels, Stijn M. Agten, Tilman M. Hackeng, Tim G. A. M. Wolfs, Daidi Fan, Matthew B. Baker, Lorenzo Moroni

Summary: This study focuses on the functionalization of scaffolds using a polymer mixing approach to immobilize VEGF-mimetic peptides. The functionalized scaffolds were validated and tested, showing potential for promoting angiogenesis and vascular tissue regeneration.

BIOACTIVE MATERIALS (2023)

Article Hematology

Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa

Tom W. Van de Berg, Erik A. M. Beckers, Floor C. J. I. Heubel-Moenen, Yvonne M. C. Henskens, M. Christella L. G. D. Thomassen, Tilman M. Hackeng

Summary: This study aims to optimize thrombin generation assays (TGAs) for better measurement of low factor VIII (FVIII) levels in severe hemophilia A (HA) patients. The use of low concentrations of tissue factor (TF) and FXIa appears to increase the sensitivity of TG to detect changes in low FVIII ranges.

THROMBOSIS AND HAEMOSTASIS (2023)

Review Nutrition & Dietetics

Vitamin K and Hallmarks of Ageing: Focus on Diet and Gut Microbiome

Lu Dai, Denise Mafra, Paul G. Shiels, Tilman M. Hackeng, Peter Stenvinkel, Leon J. Schurgers

Summary: Vitamin K and vitamin K-dependent proteins are associated with age-related diseases. The direct impact of vitamin K on cellular senescence is yet to be proven, but its status reflects the complex interactions between dietary intake, gut microbiome activity, and health. It is proposed to emphasize food quality and explore healthy eating patterns containing vitamin K rather than focusing on a single nutrient for dietary recommendations.

NUTRIENTS (2023)

Article Chemistry, Medicinal

Novel Amphibian Bowman-Birk-Like Inhibitor with Antioxidant and Anticoagulant Effects Ameliorates Pancreatitis Symptoms in Mice

Jinwei Chai, Jiena Wu, Jinqiao Li, Hang Liao, Wancheng Lu, Ruiyin Guo, Zuoyan Shao, Mohamed Amine Jmel, Larissa Almeida Martins, Tilman Hackeng, Hans Ippel, Ingrid Dijkgraaf, Michail Kotsyfakis, Xueqing Xu

Summary: A novel Ranacyclin peptide called Ranacin was identified from the skin of Pelophylax nigromaculatus frog. Ranacin effectively inhibited trypsin and exhibited anticoagulant and antioxidant activities in vitro. Treatment with Ranacin significantly alleviated the severity of pancreatitis in L-Arg-induced AP mice. Structure-activity studies suggested that sequences outside the trypsin inhibitory loop (TIL) of Ranacin may play an important role in its efficacy.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Hematology

Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residues

M. Christella L. G. D. Thomassen, Bryan R. C. Bouwens, Kanin Wichapong, Dennis P. Suylen, Freek G. Bouwman, Tilman M. Hackeng, Rory R. Koenen

Summary: This study found that PAD4 inactivates TFPI by citrullination of its arginines, and this process is time- and concentration-dependent. Furthermore, inducers of PAD4 blocked the citrullination of TFPI. This process may play a crucial role in the increased thrombosis risk associated with inflammation.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Article Nutrition & Dietetics

Dysbiosis in Patients with Chronic Kidney Disease: Let Us Talk About Vitamin K

Julie Ann Kemp, Livia Alvarenga, Ludmila F. M. F. Cardozo, Lu Dai, Peter Stenvinkel, Paul G. Shiels, Tilman M. Hackeng, Leon J. Schurgers, Denise Mafra

Summary: This narrative review summarizes the current evidence on the connection between dysbiosis and vitamin K deficiency in patients with chronic kidney disease (CKD). Recent studies in animals have shown that dysbiosis is associated with low production of vitamin K by the gut microbiota. Vitamin K plays vital roles in blood coagulation, cardiovascular and bone health, as well as antioxidant and anti-inflammatory functions. The main source of vitamin K is dietary intake, but it can also be produced by gut microbiota. Understanding the relationship between gut dysbiosis and vitamin K deficiency in CKD patients can lead to future clinical studies.

CURRENT NUTRITION REPORTS (2022)

Article Hematology

Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals

E. O. Artemenko, S. I. Obydennyi, K. S. Troyanova, G. A. Novichkova, D. Y. Nechipurenko, M. A. Panteleev

Summary: In this study, we investigated the adhesive properties of circulating plasma-derived and platelet-derived microvesicles (MVs) and their potential role in thrombus growth. The results showed that both types of MVs weakly bound fibrinogen but did not stably adhere to immobilized fibrinogen. Moreover, the presence of these MVs did not significantly affect thrombus formation. Therefore, MVs present in the plasma of healthy individuals are unlikely to directly contribute to thrombus formation under arterial flow conditions.

THROMBOSIS RESEARCH (2024)

Letter Hematology

Recent monthly mortality for pulmonary embolism in the US

Giuseppe Lippi, Camilla Mattiuzzi, Emmanuel J. Favaloro

THROMBOSIS RESEARCH (2024)

Article Hematology

Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients

Marium Malik, Maha Al-Ghafry, Abraham Haimed, Julia Su, Maribel Lema, Linda Shore-Lessersson, Suchitra S. Acharya

Summary: This study analyzed and evaluated leukemia-associated coagulopathy in newly diagnosed pediatric leukemia patients using CCTs and ROTEM. The results showed that fibrinogen and platelets played a significant role in causing coagulopathies in this population. This suggests the utility of using CCTs and ROTEM in the pediatric population to evaluate hemostatic function and guide blood product replacement.

THROMBOSIS RESEARCH (2024)

Review Hematology

Thrombotic triad in microgravity

Mohammad M. Elahi, Alexandra N. Witt, Edward L. G. Pryzdial, Paul B. McBeth

Summary: Thrombotic disease may be underdiagnosed in microgravity conditions, and the underlying factors are still poorly understood. A case of internal jugular vein thrombosis was recently diagnosed in a low-risk female astronaut, and six out of ten additional crew members showed risk factors for jugular venous flow. Observations in space and studies on Earth suggest that microgravity affects blood flow, coagulation, and vascular function.

THROMBOSIS RESEARCH (2024)

Review Hematology

Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review

Stian Ingemann-Molden, Christina Krogner Caspersen, Nanna Rolving, Anette Arbjerg Hojen, Frederikus A. Klok, Erik L. Grove, Barbara Cristina Brocki, Jane Andreasen

Summary: This study found that no single PROM covered all aspects considered important by PE patients. PROMs recommended in the ICHOM core set covered most aspects, but worrisome thoughts, hypervigilance around symptoms, and uncertainty of illness were not covered.

THROMBOSIS RESEARCH (2024)

Article Hematology

Driver gene KRAS aggravates cancer-associated stroke outcomes

Haomin Yan, Tsutomu Sasaki, Yasufumi Gon, Kumiko Nishiyama, Hideaki Kanki, Hideki Mochizuki

Summary: The incidence of cancer-associated stroke has increased with the prolonged survival times of cancer patients. In this study, the researchers focused on the driver gene KRAS and found that KRAS mutations exacerbated neurological deficits after stroke and promoted tumor growth. They also identified the upregulation of pro-inflammatory responses and the promotion of STAT3 phosphorylation in mice with KRAS mutations. Additionally, the researchers found that colorectal cancer patients with stroke onset within 3 months after cancer diagnosis had a worse prognosis.

THROMBOSIS RESEARCH (2024)

Letter Hematology

Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles

Tomoki Togashi, Satomi Nagaya, Makiko Meguro-Horike, Haruto Matsumoto, Yuta Imai, Koichi Yamaguchi, Yoshinari Fujii, Haruka Moriya, Yuika Kikuchi, Ibuki Yasuda, Shin-ichi Horike, Eriko Morishita

THROMBOSIS RESEARCH (2024)

Article Hematology

Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

Marta Najarro, Winnifer Briceno, Carmen Rodriguez, Alfonso Muriel, Sara Gonzalez, Ana Castillo, Ignacio Jara, Parth Rali, Catalin Toma, Behnood Bikdeli, David Jimenez

Summary: The CPES score is a useful tool in identifying the risk of hemodynamic deterioration in normotensive patients with acute PE, with acceptable C-statistic, excellent specificity, and low positive predictive value.

THROMBOSIS RESEARCH (2024)

Article Hematology

Trimethylamine-N-oxide (TMAO) and basic fibroblast growth factor (bFGF) are possibly involved in corticosteroid resistance in adult patients with immune thrombocytopenia

Lei Liu, Huifang Xu, Jian Wang, Haiyan Wang, Saisai Ren, Qian Huang, Mingyan Zhang, Hui Zhou, Chunyan Yang, Lu Jia, Yu Huang, Hao Zhang, Yanling Tao, Ying Li, Yanan Min

Summary: This study investigated the gut microbiota metabolites and cytokines, chemokines, and growth factors in patients with ITP and found their association with treatment responsiveness. The findings suggest that imbalanced secretion of cyto(chemo)kins/growth factors and inadequate levels of TMAO are characteristic of patients with ITP.

THROMBOSIS RESEARCH (2024)

Article Hematology

Safety of fixed-dose heparin titration boluses in underweight patients

Roxanne Mcknight, Mohammad Salameh, Lee Ann Jones, Greta Anton, Lindsay Carter

Summary: This study evaluated the safety of fixed-dose heparin titration boluses in underweight patients with VTE. The results showed that although underweight patients required more frequent holding of heparin, there was no significant increase in bleeding risk.

THROMBOSIS RESEARCH (2024)